Comparative genomics of Sneathia species: insights into pathogenicity and adaptation to the human niche

Sneathia is a genus of anaerobic bacteria increasingly recognized as a key player in the vaginal microbiome during dysbiosis, linked to conditions like bacterial vaginosis, preterm birth, and cervical cancer. Despite their clinical relevance, their fastidious nature has hindered comprehensive genetic study. This paper utilizes comparative genomics to analyze 12 whole-genome sequences (including two newly sequenced isolates) to map the pathogenic potential of the two primary species: Sneathia vaginalis and Sneathia sanguinegens.

The study reveals that both species possess small, compact genomes (1.25–1.35 Mbp) with low GC content, which are hallmarks of high adaptation to the specific, nutrient-restricted microenvironment of the human urogenital tract. Despite their shared classification, the two species demonstrate distinct metabolic strategies. S. vaginalis is better equipped for carbohydrate metabolism, including the Entner-Doudoroff pathway and the catabolism of gluconate and ascorbic acid. In contrast, S. sanguinegens possesses specialized enzymes for degrading complex host substrates like hyaluronic acid and sialic acids, suggesting a specialized capacity to breach epithelial barriers.

A critical finding is the distribution of virulence factors. The cytopathogenic toxin A (CptA), a pore-forming protein linked to cellular damage and hemolytic activity, is exclusive to S. vaginalis. However, both species share a set of core virulence factors, including putative hemolysins and adhesins, which likely facilitate colonization. The researchers propose that these distinct yet complementary metabolic and virulent profiles suggest a model of microbe-microbe cooperation, where Sneathia species work in tandem with other members of the vaginal community to persist in the host and drive adverse reproductive outcomes.